Compare GSK plc (GSK) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Williams Companies Inc — how do they compare? GSK plc trades at $52.85 (market cap $101.34B), while Williams Companies Inc trades at $74.41 (market cap $90.97B). The key difference: GSK plc and Williams Companies Inc are close in size by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | WMB | |
|---|---|---|
Market Cap | $101.34B | $90.97B |
Sector | Health | Energy |
52-Week High | $61.18 | $79.40 |
52-Week Low | $36.20 | $56.51 |
Enterprise Value | $121.95B | $120.35B |
Dividend Yield | 3.49% | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Williams Companies (WMB) trades at $74.76, down 1.61% on the day, with a neutral technical outlook and strong analyst support. The stock shows robust profitability with a 23.4% net margin and 21.95% ROE, while recent news highlights a $5.34 billion Blackstone-led investment for power projects. Cash flow trends improved in 2025, with net cash flow turning positive to $3 million after a 2024 deficit.
WMB presents a favorable long-term outlook with a consensus price target of $85.67 and no sell ratings among analysts. Risks include high debt levels and exposure to natural gas price volatility, but the company's fee-based midstream model and strategic investments in energy infrastructure support dividend growth and earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
